IBD Pipeline

AstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD Pipeline

AstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD PipelineAstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD Pipeline

Thursday, the FDA supported AstraZeneca and Merck's Lynparza (olaparib) for the therapy of grown-ups with metastatic emasculation safe prostate malignant…